CDEK
← All trials

NCT06624644

Phase 2/Phase 3Interventional

Trials that are a combination of phases 2 and 3.

View on ClinicalTrials.gov ↗

Timeline

Start date
Nov 30, 2024
Primary completion
Aug 31, 2028
Completion date
Aug 31, 2030
First posted
Oct 3, 2024
Last posted
Oct 8, 2024
Enrollment
135
Arms / groups
3 / —
Source
AACT · ctgov ingestion

Sponsors

Drugs studied

Indications studied

CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.